Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery

Clarke, 2010, Leptomeningeal metastases in the MRI era, Neurology, 74, 1449, 10.1212/WNL.0b013e3181dc1a69 Dankner, 2021, The underlying biology and therapeutic vulnerabilities of leptomeningeal metastases in adult solid cancers, Cancers, 13, 732, 10.3390/cancers13040732 Brower, 2016, Ian Robins H. Management of leptomeningeal metastases: Prognostic factors and associated outcomes, J Clin Neurosci, 27, 130, 10.1016/j.jocn.2015.11.012 Nayar, 2017, Leptomeningeal disease: Current diagnostic and therapeutic strategies, Oncotarget, 8, 73312, 10.18632/oncotarget.20272 Le Rhun, 2017, EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours, Ann Oncol, 28, iv84, 10.1093/annonc/mdx221 Yamada, 2008, High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions, Int J Radiat Oncol Biol Phys, 71, 484, 10.1016/j.ijrobp.2007.11.046 Gerszten, 2009, Radiotherapy and radiosurgery for metastatic spine disease: What are the options, indications, and outcomes?, Spine, 34, S78, 10.1097/BRS.0b013e3181b8b6f5 Gerszten, 2007, Radiosurgery for spinal metastases: Clinical experience in 500 cases from a single institution, Spine, 32, 193, 10.1097/01.brs.0000251863.76595.a2 Chang, 2007, Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure, J Neurosurg Spine, 7, 151, 10.3171/SPI-07/08/151 Ozdoba, 2011, Myelography in the age of MRI: Why we do it, and how we do it, Radiol Res Pract, 2011 American College of Radiology. ACR–ASNR–SPR practice parameter for the performance of myelography and cisternography. Available at: https://www.acr.org/-/media/ACR/Files/Practice-Parameters/myelog-cisternog.pdf. Accessed July 28, 2021. Cox, 2012, International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery, Int J Radiat Oncol Biol Phys, 83, e597, 10.1016/j.ijrobp.2012.03.009 Bubendorf, 2000, Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients, Hum Pathol, 31, 578, 10.1053/hp.2000.6698 Geldof, 1997, Models for cancer skeletal metastasis: A reappraisal of Batson's plexus, Anticancer Res, 17, 1535 Wasserstrom, 1982, Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients, Cancer, 49, 759, 10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7 Yamada, 2007, A review of image-guided intensity-modulated radiotherapy for spinal tumors, Neurosurgery, 61, 226, 10.1227/01.NEU.0000279970.10309.B5 Chamberlain, 2017, Leptomeningeal metastases: A RANO proposal for response criteria, Neuro-Oncol, 19, 484 Jaeckle, 2001, Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine, Br J Cancer, 84, 157, 10.1054/bjoc.2000.1574 Gleissner, 2006, Neoplastic meningitis, Lancet Neurol, 5, 443, 10.1016/S1474-4422(06)70443-4 Le Rhun, 2021, Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors, Neuro-Oncol, 23, 1100, 10.1093/neuonc/noaa298 Remsik, 2020, Leptomeningeal metastatic cells adopt two phenotypic states, Cancer Rep (Hoboken), 5, e1236, 10.1002/cnr2.1236 Umemura, 2012, Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama Lung Cancer Study Group, Lung Cancer, 77, 134, 10.1016/j.lungcan.2012.03.002 Morris, 2012, Leptomeningeal metastasis from non-small cell lung cancer: Survival and the impact of whole brain radiotherapy, J Thorac Oncol, 7, 382, 10.1097/JTO.0b013e3182398e4f Raizer, 2008, Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features, Neuro-Oncol, 10, 199, 10.1215/15228517-2007-058 Lara-Medina, 2012, Clinical features and prognostic factors in patients with carcinomatous meningitis secondary to breast cancer, Breast J, 18, 233, 10.1111/j.1524-4741.2012.01228.x Harstad, 2008, Prognostic factors and outcomes in patients with leptomeningeal melanomatosis, Neuro-Oncol, 10, 1010, 10.1215/15228517-2008-062 Temel, 2010, Early palliative care for patients with metastatic non-small-cell lung cancer, N Engl J Med, 363, 733, 10.1056/NEJMoa1000678 Glass, 1979, Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology, Neurology, 29, 1369, 10.1212/WNL.29.10.1369 Yang, 2021, Clinical trial of proton craniospinal irradiation for leptomeningeal metastases, Neuro-Oncol, 23, 134, 10.1093/neuonc/noaa152 Yang, 2022, Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis, J Clin Oncol, 40, 3858, 10.1200/JCO.22.01148 Nevel, 2018, The utility of liquid biopsy in central nervous system malignancies, Curr Oncol Rep, 20, 60, 10.1007/s11912-018-0706-x van Bussel, 2020, Circulating epithelial tumor cell analysis in CSF in patients with leptomeningeal metastases, Neurology, 94, e521, 10.1212/WNL.0000000000008751 Malani, 2020, Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer, J Neurooncol, 148, 599, 10.1007/s11060-020-03555-z Torre, 2020, Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis, J Am Soc Cytopathol, 9, 45, 10.1016/j.jasc.2019.09.001 Lin, 2017, Cerebrospinal fluid circulating tumor cells: A novel tool to diagnose leptomeningeal metastases from epithelial tumors, Neuro-Oncol, 19, 1248, 10.1093/neuonc/nox066 Nevel, 2020, A retrospective, quantitative assessment of disease burden in patients with leptomeningeal metastases from non-small-cell lung cancer, Neuro-Oncol, 22, 675, 10.1093/neuonc/noz208 van Bussel, 2018, EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid, J Neurooncol, 137, 1, 10.1007/s11060-017-2691-6 Cordone, 2017, Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: A cerebrospinal fluid flow cytometry study, Breast Cancer Res, 19, 46, 10.1186/s13058-017-0827-4 Le Rhun, 2013, Detection and quantification of CSF malignant cells by the CellSearch technology in patients with melanoma leptomeningeal metastasis, Med Oncol, 30, 538, 10.1007/s12032-013-0538-3 Pentsova, 2016, Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid, J Clin Oncol, 34, 2404, 10.1200/JCO.2016.66.6487 Smalley, 2020, Proteomic analysis of CSF from patients with leptomeningeal melanoma metastases identifies signatures associated with disease progression and therapeutic resistance, Clin Cancer Res, 26, 2163, 10.1158/1078-0432.CCR-19-2840 Ying, 2019, Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases, Cancer Biol Ther, 20, 562, 10.1080/15384047.2018.1538614 Pan, 2020, Identification of cerebrospinal fluid microRNAs associated with leptomeningeal metastasis from lung adenocarcinoma, Front Oncol, 10, 387, 10.3389/fonc.2020.00387 Suryavanshi, 2020, CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer, Lung Cancer, 148, 33, 10.1016/j.lungcan.2020.07.034 Boire, 2019, Liquid biopsy in central nervous system metastases: A RANO review and proposals for clinical applications, Neuro-Oncol, 21, 571, 10.1093/neuonc/noz012